作者:
Juan,Flores-Montero [1]
;
Tomas,Kalina [2]
;
Alba,Corral-Mateos [1]
;
Luzalba,Sanoja-Flores [1]
;
Martin,Pérez-Andrés [1]
;
Marta,Martin-Ayuso [3]
;
Lukasz,Sedek [4]
;
Katerina,Rejlova [2]
;
Andrea,Mayado [1]
;
Paula,Fernández [5]
;
Vincent,van der Velden [6]
;
Sebastian,Bottcher [7]
;
Jaques J M,van Dongen [8]
;
Alberto,Orfao [9]
作者单位:
Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) CB16/12/00400, Instituto de Salud Carlos III, Madrid, Spain.
[1]
CLIP Cytometry, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
[2]
Cytognos SL, Salamanca, Spain.
[3]
Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland.
[4]
FACS/Stem cell Laboratory, Institute of Laboratory Medicine, Kantonsspital Aarau AG, Aarau, Switzerland.
[5]
Department of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands.
[6]
Rostock University Medical Center, Division of Internal Medicine, Medical Clinic III, Hematology, Oncology and Palliative Medicine, Special Hematology Laboratory, Rostock, Germany.
[7]
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: J.J.M.van_Dongen@lumc.nl.
[8]
Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) CB16/12/00400, Instituto de Salud Carlos III, Madrid, Spain.. Electronic address: orfao@usal.es.
[9]
DOI
10.1016/j.jim.2019.06.009
PMID
31181212
发布时间
2020-05-11